5 Key Takeaways

• 1

  Distinct neurodegenerative diseases exhibit specific chemical signatures of tau protein, challenging the uniform approach to tau-related dementia.

• 2

  Tau aggregation is a hallmark of over 20 neurodegenerative conditions, including Alzheimer's disease and chronic traumatic encephalopathy.

• 3

  Researchers analyzed post-mortem brain tissue from 203 individuals to characterize pathological tau using a quantitative mass-spectrometry workflow.

• 4

  The study identified 145 post-translational modifications and 195 cleavage sites, revealing unique patterns for each tauopathy.

• 5

  Machine learning models ranked tau modifications by importance, providing a roadmap for diagnostics and therapeutic development.